Key result
High-risk N2 sleep HRV phenotype is linked to ~47% higher risk of incident CVD.
Why the study?
Sleep stage-specific heart rate variability phenotypes and their associations with long-term cardiovascular outcomes were not well characterized.
Do sleep stage-specific HRV-based phenotypes predict long-term incident CVD and all-cause mortality independently of conventional sleep apnea metrics?
Cohort (n=4,029)
Do sleep stage-specific HRV-based phenotypes predict long-term incident CVD and all-cause mortality independently of conventional sleep apnea metrics?
Hazard Ratio: 1.468 (95% CI 1.28–1.684)
p-value: p=<0.001
Sleep stage-specific HRV-informed phenotyping provides complementary prognostic information beyond traditional respiratory severity metrics to improve cardiovascular risk stratification in obstructive sleep apnea.
N2 sleep metrics should not yet guide CVD risk assessment; leaves open independent predictive value beyond sleep phenotypes.
Aim To identify sleep stage-specific heart rate variability (HRV) phenotypes and evaluate their associations with long-term cardiovascular outcomes. Methods Data were obtained from the Sleep Heart Health Study (SHHS). After exclusion of participants with missing clinical covariates or outcome data, 4,029 individuals were included. Linear and non-linear HRV features were extracted from stage-specific electrocardiographic segments during N2, N3, and REM sleep. Results Three HRV-informed phenotypes were identified within the selected clustering framework across N2, N3, and REM sleep stages: Stable (Cluster 0), Burden (Cluster 1), and High-risk (Cluster 2). Compared with Stable phenotype, High-risk phenotype was consistently associated with increased cardiovascular risk, with strongest association observed for incident CVD in N2 stage (HR 1.468, 95% CI 1.280–1.684, P < 0.001). Similar associations were observed in N3 and REM stages. Sequential adjustment for AHI, oxygen desaturation index, arousal index, and sleep efficiency resulted in only minimal attenuation of hazard estimates, indicating that the prognostic associations were largely independent of conventional respiratory measures. In contrast, Burden phenotype was consistently associated with lower all-cause mortality across all three sleep stages (HR range 0.83–0.85, all P < 0.001). Subgroup analyses stratified by OSA severity demonstrated broadly consistent prognostic associations across AHI strata. Conclusions Incorporating sleep stage-specific HRV features into conventional clinical phenotyping provides complementary prognostic information beyond traditional respiratory severity metrics. HRV-informed phenotyping may improve long-term cardiovascular risk stratification in patients with obstructive sleep apnea.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a cohort in Obstructive sleep apnea (n=4,029). High-risk heart rate variability phenotype vs. Stable heart rate variability phenotype was evaluated on Incident cardiovascular disease (HR 1.468, 95% CI 1.280-1.684, p=<0.001). A high-risk heart rate variability phenotype during the N2 sleep stage was significantly associated with increased risk of incident cardiovascular disease compared to a stable phenotype (HR 1.468; 95% CI 1.280-1.684; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: